Onglyza

AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe
Fierce Pharma
Wed, 07/20/16 - 11:02 am
AstraZeneca
diabetes
Europe
FDA
Qtern
Farixga
Onglyza
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Diabetes drugs fuel cancer spread in mouse study
Stat
Wed, 04/13/16 - 10:26 pm
diabetes
cancer
Merck
Januvia
AstraZeneca
Onglyza
Two drug makers complain India is thwarting licenses for selling generics
Stat
Wed, 04/13/16 - 11:46 am
India
Lee Pharma
BDR Pharma
generics
Sprycel
Bristol-Myers Squibb
AstraZeneca
Onglyza
FDA warns on heart failure risk associated with Onglyza, Nesina
BioPharma Dive
Wed, 04/6/16 - 10:13 pm
FDA
heart failure
Onglyza
Nesina
AstraZeneca
Takeda
diabetes
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
FDA
diabetes
joint pain
DPP-4 inhibitor
Merck
Januvia
Onglyza
AstraZeneca
Takeda
Boehringer Ingelheim
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Wed, 08/26/15 - 10:43 am
AstraZeneca
cardiovascular disease
metabolic disorders
Onglyza
Crestor
Brilinta
Express Scripts excludes 20 more drugs from 2016 coverage
Yahoo/Reuters
Sat, 08/1/15 - 09:12 am
Express Scripts
formulary
Vivus
Qsymia
AstraZeneca
Onglyza
AdverseEvents: Diabetes drug analysis flags heart failure, pancreatitis reports
Fierce Pharma
Tue, 06/16/15 - 12:08 pm
diabetes
side effects
heart failure
pancreatitis
Nesina
Takeda
Onglyza
AstraZeneca
Farixga
Byetta
Victoza
Januvia
Merck
Novo Nordisk
Merck Gains Edge on Rivals With Results About its Diabetes Drug
WSJ Pharmalot
Wed, 04/29/15 - 09:20 am
Merck
diabetes
Januvia
AstraZeneca
Onglyza
Nesina
Safety scare with AstraZeneca's diabetes drug could shake up the DPP-4 field
Fierce Biotech
Fri, 04/10/15 - 03:54 pm
AstraZeneca
Onglyza
diabetes
DPP-4 inhibitor
Takeda
Merck
Nesina
Januvia
FDA: Data suggests AstraZeneca drug may increase death rate
Yahoo/Reuters
Fri, 04/10/15 - 10:44 am
AstraZeneca
FDA
Onglyza
diabetes
AZ's Onglyza has most to lose at FDA safety confab, analysts say
Fierce Pharma
Thu, 04/9/15 - 11:52 am
FDA
Onglyza
diabetes
AstraZeneca
FDA Onglyza panel review set for Tuesday
Medical Marketing and Media
Wed, 04/8/15 - 05:19 pm
FDA
advisory panels
Onglyza
diabetes
AstraZeneca
FDA to review possible heart risks with AstraZeneca's diabetes drug
Yahoo/Reuters
Tue, 02/11/14 - 10:35 am
FDA
AstraZeneca
diabetes
Onglyza
Update on AstraZeneca's Onglyza
Yahoo/Zacks
Wed, 10/2/13 - 10:03 am
Onglyza
AstraZeneca
diabetes
Bristol-Myers: Interesting Investing Opportunity With Onglyza
Seeking Alpha
Sat, 09/28/13 - 12:15 pm
type 2 diabetes
Onglyza
diabetes
Bristol-Myers Squibb
AstraZeneca
AstraZeneca Reports Onglyza Data
Yahoo/Zacks
Wed, 09/4/13 - 08:57 am
Onglyza
AstraZeneca
diabetes
AstraZeneca, Bristol diabetes drug disappoints in key test
Reuters
Wed, 06/19/13 - 10:28 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Onglyza
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim

Pages